Movember – Focusing on social awareness about men’s health
Prevention is the best ally for diseases affecting men's health
November has been established as the month of social awareness about men’s health, with the characteristic name "Movember". The specific movement aims to raise awareness about prostate cancer, the second most common type of cancer among men worldwide, as well as men's mental health.
The word Movember derives from the combination of the words “mustache” and “November”. The "Movember" movement started in 2003 in Australia, by a group of 30 friends – and has now turned into a global movement. Movember has been active in Cyprus since 2012, with the slogan "we change the face of male cancer", and the response from the public has been increasing each year ever since.
Movements like Movember, which aim at raising public awareness and support, have proved to have significant positive effects. Since Movember’s initiation, more than 1,200 men’s health programs have been funded worldwide. By 2030, the movement aims its actions will reduce men’s premature deaths by 25%.
Characteristics of prostate cancer
When we refer to the prostate, we refer to the gland that is located below the bladder and surrounds the urethra. It is usually the size and shape of a walnut and grows throughout a man's life. The main function of the prostate is to help in the production of sperm. Prostate cancer occurs when cells in the prostate begin to develop uncontrollably. Most of the times, prostate cancer doesn’t have any early symptoms, until the tumor begins to grow. In cases where the cancer is detected in its early stages, before it metastasizes to other organs, prognosis is excellent. Regular examinations are crucial in the case of prostate cancer because they enable early detection and immediate action. Some of the symptoms associated with prostate cancer are the need for frequent urination, especially at night, difficulty in starting to urinate, poor flow, the feeling that the bladder is not completely empty after urination, and blood in urine or semen. Factors such as age, ethnicity, family history, obesity and diet have been directly linked to an increased risk of developing prostate cancer.
High incidence of prostate cancer has been recorded worldwide. Particularly, 1 in 9 men in the general population will develop prostate cancer in their lifetime. The incidence risk and mortality rates for prostate cancer are directly related to increasing age. It is estimated that for men under the age of 50, only 1 in 350 men (incidence rate 0.28%) have a risk of developing prostate cancer. However, for older men between the ages of 50-59, the incidence rate increases almost six times, with 1 in 52 men (incidence rate 1.92%) being at risk of developing prostate cancer.
In Cyprus, recent studies show that the rate of cancer incidence is increasing, with prostate cancer being the most prevalent form of cancer among men. According to the World Health Organization (WHO) for the year 2018, 751 new cases of prostate cancer were recorded in Cyprus, accounting for 28.6% of all new cases of cancer on the island.
As is the case with cancer and other diseases, prevention is the best cure. Provision of adequate information to the public is necessary for prevention of prostate cancer, so that men are in a position to recognize symptoms or signs relating to prostate cancer, and know when to seek help. Innovative genetic tests which help detect the disease while still in its early stages and in taking informed decisions are allies in the fight against prostate cancer. PreSENTIA is a cutting-edge genetic test that can detect multiple hereditary genetic mutations, which can be passed down from generation to generation, and could develop into cancer in the future. PreSENTIA offers specialized panels for prostate cancer, of which up to 10% is hereditary. If a person has family history of prostate cancer, PreSENTIA can help identify the hereditary mutation responsible for causing cancer.
For people that have already been diagnosed with prostate cancer, there are tests for tumor molecular profiling, such as the genetic test ForeSENTIA. Each tumor has distinct molecular composition and is caused by different mutations in the DNA. ForeSENTIA has a specialized panel for prostate cancer, as well as for the most common types of cancer. When the genetic mutation that caused the cancer development is detected, it allows patients to receive targeted treatment, while increasing the chances of the treatment being effective. Both PreSENTIA and ForeSENTIA genetic tests were developed in Cyprus, and are offered in multiple countries abroad, providing results with 99,9% accuracy.
NIPD Genetics values your interest in NIPD Genetics, its products and its services. NIPD Genetics takes the protection of your data seriously.
You may contact NIPD Genetics Public Company Ltd at NIPD Genetics Public Company Ltd Neas Engomis 31 Engomi, Nicosia 2409, Cyprus
NIPD Genetics Data Protection Officer can be reached at email@example.com
Type of personal information NIPD Genetics may collect through its Sites
The ways by which NIPD Genetics collects, uses or shares such information
Steps NIPD Genetics takes to protect its sites’ users personal information
This page informs you of our policies regarding the collection, use, and disclosure of personal data when you use our Sites and the choices you have associated with that data.
Type of personal information NIPD Genetics may collect through its Sites
Information Collection And Use
We collect several different types of information for various purposes to provide and improve our Sites and services to you.
While using NIPD Genetics Sites, you may be asked to provide NIPD Genetics certain personally identifiable information that can be used to contact or identify you ("Personal Information"). Personal Information that might be used to identify you includes, but is not limited to:
First name and last name
Address, State, Province, ZIP/Postal code, City
If you send us a query via our Contact us form, your email address, the content and any follow up emails are retained indefinitely.
Cookies and Usage Data
We may also collect information how the Sites are accessed and used ("Usage Data"). This Usage Data may include information such as your computer's Internet Protocol address (e.g. IP address), browser type, browser version, the pages of our Sites that you visit, the time and date of your visit, the time spent on those pages, unique device identifiers and other diagnostic data.
Tracking & Cookies Data
Cookies are files with small amount of data which may include an anonymous unique identifier. Cookies are sent to your browser from a website and stored on your device. Tracking technologies also used are beacons, tags, and scripts to collect and track information and to improve and analyze our Sites.
You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our Sites.
Examples of Cookies we use:
Session Cookies. We use Session Cookies to operate our Sites.
Preference Cookies. We use Preference Cookies to remember your preferences and various settings.
Security Cookies. We use Security Cookies for security purposes.
Visitor behavior cookies. To understand how visitors use and navigate the Sites
Keyword cookies. To understand how visitors discover the Sites.
Use of Data
www.nipd.com uses the collected data for various purposes:
To provide and maintain the Sites
To notify you about changes to our Sites
To allow you to participate in interactive features of our Sites when you choose to do so
To provide customer care and support
To provide analysis or valuable information so that we can improve the Sites
To monitor the usage of the Sites
To detect, prevent and address technical issues
Transfer of Data
Your information, including personal data, may be transferred to — and maintained on — computers located outside of your province, country or other governmental jurisdiction where the data protection laws may differ than those from your jurisdiction.
If you are located outside Cyprus and choose to provide information to us, please note that we transfer the data, including personal data, to Cyprus and process it there.
Disclosure of Data
NIPD Genetics complies with the protection of personal data regulation and will not sale or trade your personal data.
NIPD Genetics may disclose your personal data in the good faith belief that such action is necessary to:
To comply with a legal obligation
To protect and defend the rights or property of www.nipd.com
To prevent or investigate possible wrongdoing in connection with the Sites
To protect the personal safety of users of the Sites or the public
To protect against legal liability
Security of Data
The security of your data is important to us, but remember that no method of transmission over the Internet, or method of electronic storage is 100% secure. While we strive to use commercially acceptable means to protect your Personal Data, we cannot guarantee its absolute security.
We may employ third party companies and individuals to facilitate, maintain or operate our Sites ("Service Providers"), to provide the SItes on our behalf, to perform service-related services or to assist us in analyzing how our Sites is used.
These third parties have access to your Personal Data only to perform these tasks on our behalf and are obligated not to disclose or use it for any other purpose.
We may use third-party Service Providers to monitor and analyze the use of our Sites.
Google Analytics is a web analytics service offered by Google that tracks and reports website traffic. Google uses the data collected to track and monitor the use of our Service. This data is shared with other Google services. Google may use the collected data to contextualize and personalize the ads of its own advertising network.
Access to your personal data, correction, deletion, and Opting Out
You have the right to review, update or delete any of your personal data by sending a request at NIPD Genetics Personal Data Officer firstname.lastname@example.org
Links to Other Sites
We have no control over and assume no responsibility for the content, privacy policies or practices of any third-party sites or services.
Our Service does not address anyone under the age of 18 ("Children").
We do not knowingly collect personally identifiable information from anyone under the age of 18. If you are a parent or guardian and you are aware that your Children has provided us with Personal Data, please contact us. If we become aware that we have collected Personal Data from children without verification of parental consent, we take steps to remove that information from our servers.